Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Double-blind Parallel Group Trial to Study the Effects of an Infant Formula Containing Bio-active Ingredients on Immune Parameters, Gut Health and Growth in Healthy Term Infants.

NCT07867509 is registered in ClinicalTrials.gov with FrieslandCampina as lead sponsor.

NCT NCT07867509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07867509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Double-blind Parallel Group Trial to Study the Effects of an Infant Formula Containing Bio-active Ingredients on Immune Parameters, Gut Health and Growth in Healthy Term Infants.
Lead sponsor
FrieslandCampina
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
December 31, 2028
Enrollment
387 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infant all